Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label comparison of three herbal medicinal products for acute bronchitis
2023-507370-41-00Phase 4Completed
- Sponsor
- Engelhard Arzneimittel
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute bronchitis comparing Bronchicum Tropfen, Bronchipret Tropfen and Prospan Hustentropfen (3 arms). Primary endpoint: Change of BSS between visit V1 (baseline) and visit V6 (7 days of treatment). Started Feb 2024; status: completed.
02
Drugs
Bronchicum TropfenBronchipret Tropfenprospan
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2023-507370-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507370-41-00.